YAC transgenic mice carrying pathological alleles of the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit

Human Molecular Genetics

Volumn 11, Issue 9, 2002, Pages 1075-1094

  Cemal, Cemal K ^a   Carroll, Christopher J ^a   Lawrence, Lorraine ^a   Lowrie, Margaret B ^a   Ruddle, Piers ^a   Al Mahdawi, Sahar ^a   King, Rosalind H M ^b   Pook, Mark A ^a   Huxley, Clare ^a   Chamberlain, Susan ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; GUANINE; POLYGLUTAMINE;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LOSS; CELL NUCLEUS INCLUSION BODY; CEREBELLUM DISEASE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMYELINATION; DENTATE NUCLEUS; DISEASE COURSE; DISEASE SEVERITY; GENE LOCUS; HOMOLOGOUS RECOMBINATION; MACHADO JOSEPH DISEASE; MOTOR DYSFUNCTION; MOUSE; MUSCLE HYPOTONIA; NERVE CELL; NERVE FIBER; NONHUMAN; PATHOGENESIS; PERIPHERAL NERVE; PONS ANGLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; SENSORY DYSFUNCTION; SYMPTOM; TISSUE SPECIFICITY; TRANSGENIC MOUSE; TRINUCLEOTIDE REPEAT; WILD TYPE; YEAST ARTIFICIAL CHROMOSOME;

ANIMALIA; MUS MUSCULUS;

EID: 0036566229     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/11.9.1075     Document Type: Article

References (75)

1. Spinocerebellar ataxia type 1 and Machado-Joseph disease: Incidence of CAG expansions among adult-onset ataxia patients from 311 families with dominant, recessive, or sporadic ataxia
2. Autosomal dominant system degeneration in Portuguese families of the Azores Islands: A new genetic disorder involving cerebellar, pyramidal, extrapyramidal and spinal cord motor functions
3. Machado-Joseph disease: An autosomal dominant motor system degeneration
4. A clinical and pathologic study of a large Japanese family with Machado-Joseph disease tightly linked to the DNA markers on chromosome 14q
5. Age related axonal neuropathy in spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD)
6. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1
7. The genomic structure and expression of MJD, the Machado-Joseph disease gene
8. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
9. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
10. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length
11. Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain
12. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures
13. Chaperone suppression of aggregation and altered subcellular proteasome localisation imply protein misfolding in SCA1
14. Intranuclear neuronal inclusions in DRPLA
15. Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy
16. Spinocerebellar ataxia type 7 (SCA7): A neurodegenerative disorder with neuronal intranuclear inclusions
17. Identification and localization of ataxin-7 in brain and retina of a patient with cerebellar ataxia type II using anti-peptide antibody
18. Neuronal intranuclear inclusions in SCA2: A genetic, morphological and immunohistochemical study of two cases
19. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein
20. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila
21. Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA
22. Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice
23. SCA7 mouse models show selective stabilization of mutant ataxin-7 and similar cellular responses in different neuronal cell types
24. Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo
25. SCA1 transgenic mice: A model for neurodegeneration caused by an expanded CAG trinucleotide repeat
26. Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations
27. Joseph disease: A multisystem degenerative disorder of the nervous system
28. Joseph's disease: Clinical and pathological studies in a Japanese family
29. Spinocerebellar ataxia 3 and Machado-Joseph disease: Clinical, molecular, and neuropathological features
30. Insertion of expanded CAG trinucleotide repeat motifs into a yeast artificial chromosome containing the human Machado-Joseph disease gene
31. A commentary on the practical applications of competitive PCR
32. Heterogeneous intracellular localization and expression of ataxin-3
33. Ataxin-3 with an altered conformation that exposes the polyglutamine domain is associated with the nuclear matrix
34. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias
35. Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment
36. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration
37. Clinico-pathological study of the peripheral nervous system in Machado-Joseph disease
38. The peripheral neuropathy in Machado-Joseph disease
39. Clinico-pathological study of the peripheral nervous system in Machado-Joseph disease
40. Correlation of peripheral nerve fiber loss and trinucleotide instability in Machado-Joseph disease
41. Machado-Joseph disease in three Scandinavian families
42. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3
43. Cleavage, aggregation and toxicity of the expanded androgen receptor in spinal and bulbar muscular atrophy
44. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture
45. Cleavage of atrophin-1 at caspase site aspartic acid 109 modulates cytotoxicity
46. Characterization of the rat spinocerebellar ataxia type 3 gene
47. Body weight and dietary factors in Huntington's disease patients compared with matched controls
48. Cyclin D1 provides a link between development and oncogenesis in the retina and breast
49. The winged helix gene, Mf3, is required for normal development of the diencephalon and midbrain, postnatal growth and the milk-ejection reflex
50. Targeted inactivation of Hoxb8 affects survival of a spinal ganglion and causes aberrant limb reflexes
51. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
52. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA
53. Neurological abnormalities in a knock-in mouse model of Huntington's disease
54. The pathology of Machado-Joseph disease: Report of a possible homozygous case
55. Homozygous inheritance of the Machado-Joseph disease gene
56. Unique features of the CAG repeats in Machado-Joseph disease
57. Machado-Joseph disease: Correlation between the clinical features, the CAG repeat length and homozygosity for the mutation
58. Homozygosity for Machado-Joseph disease gene enhances phenotypic severity
59. Correlation between CAG repeat length and clinical features in Machado-Joseph disease
60. CAG repeat number correlates with the rate of brainstem and cerebellar atrophy in Machado-Joseph disease
61. Progressive atrophy of cerebellum and brainstem as a function of age and the size of the expanded CAG repeats in the MJD1 gene in Machado-Joseph disease
62. Positron emission tomography (PET) in Machado-Joseph disease
63. Type III Machado-Joseph disease in a Japanese family: A clinicopathological study with special reference to the peripheral nervous system
64. Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains
65. When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases
66. Intranuclear neuronal inclusions: A common pathogenic mechanism for glutamine-repeat neurodegenerative diseases?
67. Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human
68. Dentatorubral and pallidoluysian atrophy (DRPLA). Clinical and neuropathological findings in genetically confirmed North American and European pedigrees
69. Exploring gene function: Use of yeast artificial chromosome transgenesis
70. Transgenic mice containing a 248-kb yeast artificial chromosome carrying the human betaglobin locus display proper developmental control of human globin genes
71. Development of early postnatal peripheral nerve abnormalities in Trembler-J and PMP22 transgenic mice